An injection that blocks the activity of a protein involved in aging reverses naturally occurring cartilage loss in the knee joints of old mice, a Stanford Medicine-led study has found. The treatment also prevented the development ...
1 hour ago
0
0
Bird flu viruses are a particular threat to humans because they can replicate at temperatures higher than a typical fever, one of the body's ways of stopping viruses in their tracks, according to new research led by the universities ...
1 hour ago
0
0
Lockdown and social distancing measures during the COVID-19 pandemic were associated with increased developmental concerns about young children in Scotland, research suggests.
1 hour ago
0
0
There is new hope for people who have lost their smell. Scientists have successfully tested a breakthrough device that lets people detect the presence of certain odors. This innovative system helps them "smell" again by translating ...
While reflecting on what we're thankful for during the holiday season, we often focus on the external: the company of loved ones. The nourishment of a shared meal. The homes in which we gather.
2 hours ago
0
0
In preclinical studies, researchers found that priming the immune system with a Treg-expanding therapy before stem cell transplant boosted survival, protected vital organs, and promoted a balanced gut microbiome—offering ...
2 hours ago
0
0
Ribosomes, the protein factories of the cell, are essential for all living organisms. They bind to mRNA and move along the messenger molecule, reading the genetic code as they go. Using this information, they link amino acids ...
3 hours ago
0
0
Artificial intelligence (AI) tools designed to automatically document patient visits show promise in reducing the time physicians spend on paperwork and may improve their work experience, according to a new randomized clinical ...
3 hours ago
0
0
Alcohol use disorder (AUD) is among the most widespread substance use disorders (SUDs) worldwide, characterized by an impaired ability to control the intake of alcohol. For many years, psychologists and psychiatrists have ...
An international team of investigators has reported results from the first Phase III clinical trials of rocatinlimab, a novel treatment for moderate-to-severe atopic dermatitis (eczema).
8 hours ago
0
0
